Cite
HARVARD Citation
Sukeishi, A. et al. (2022). Population pharmacokinetic modeling of GS‐441524, the active metabolite of remdesivir, in Japanese COVID‐19 patients with renal dysfunction. CPT: pharmacometrics & systems pharmacology. pp. 94-103. [Online].